Literature DB >> 8946543

High-resolution MR imaging of the breast: clinical context.

S G Orel1, M G Hochman, M D Schnall, C Reynolds, D C Sullivan.   

Abstract

Preliminary investigation into magnetic resonance (MR) imaging as a breast imaging technique has demonstrated several promising roles for this modality when used as an adjunct to mammography for the detection and diagnosis of breast cancer. There are many technical factors that must be considered, including high resolution, rapid imaging, fat suppression, and localization and biopsy capability. Potential clinical applications include differentiating benign from malignant lesions, detecting cancer when results of clinical examination or conventional imaging are equivocal, detecting cancer recurrence after breast conservation treatment, staging newly diagnosed breast cancer, and detecting occult cancer in patients presenting with axillary node metastasis. Pitfalls include false-positive and false-negative results. Awareness of the strengths and limitations of MR imaging of the breast will facilitate integration of this technique into the work-up of patients with suspicious breast lesions.

Entities:  

Mesh:

Year:  1996        PMID: 8946543     DOI: 10.1148/radiographics.16.6.8946543

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  3 in total

Review 1.  Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?

Authors:  Francesco Sardanelli; Franca Podo
Journal:  Eur Radiol       Date:  2006-09-29       Impact factor: 5.315

2.  The role of sonography in patients with breast cancer presenting as an axillary mass.

Authors:  Sun Young Park; Eun-Kyung Kim; Ki Keun Oh; Kyong Sik Lee; Byeong-Woo Park
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

3.  Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.

Authors:  N R Jagannathan; M Kumar; V Seenu; O Coshic; S N Dwivedi; P K Julka; A Srivastava; G K Rath
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.